Guardion Health Sciences, Inc. Contracts & Agreements
78 Contracts & Agreements
- Business Finance (48 contracts)
- Business Operations (1)
- Human Resources (17)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (9)
- Consulting Agreement effective January 1, 2025 (Filed With SEC on December 26, 2024)
- General Release Agreement dated December 23, 2024 (Filed With SEC on December 26, 2024)
- Separation Agreement and General Release, dated July 10, 2024, by and between Guardion Health Sciences, Inc. and Craig Sheehan (Filed With SEC on July 15, 2024)
- Amendment to Employment Agreement, dated as of April 3, 2024, by and between Guardion Health Sciences, Inc. and Craig Sheehan (Filed With SEC on April 9, 2024)
- Amendment to Employment Agreement, dated as of April 3, 2024, by and between Guardion Health Sciences, Inc. and Katie Cox (Filed With SEC on April 9, 2024)
- Amendment to Employment Agreement, dated as of April 3, 2024, by and between Guardion Health Sciences, Inc. and Janet Hall (Filed With SEC on April 9, 2024)
- Description of Securities (Filed With SEC on March 29, 2024)
- Equity Purchase Agreement by and among Doctors Best Inc., Activ Nutritional, LLC, Viactiv Nutritionals, Inc. and Guardion Health Sciences, Inc. dated as of January 30, 2024 (Filed With SEC on January 31, 2024)
- Employment Agreement dated as of September 21, 2023 by and between Guardion Health Sciences, Inc. and Katie Cox (Filed With SEC on September 26, 2023)
- Retention Agreement dated as of May 18, 2023 by and between Guardion Health Sciences, Inc. and Katherine Cox (Filed With SEC on July 31, 2023)
- Bonus Agreement by and between the Company and Craig Sheehan dated June 1, 2023 (Filed With SEC on June 5, 2023)
- Employment Agreement by and between the Company and Janet Hall dated May 28, 2023 (Filed With SEC on May 30, 2023)
- Description of Securities (Filed With SEC on April 17, 2023)
- Form of Side Letter between Guardion Health Sciences, Inc. and each investor, dated November 29, 2022 (Filed With SEC on December 2, 2022)
- Form of Registration Rights Agreement between Guardion Health Sciences, Inc. and the investors thereto, dated November 29, 2022 (Filed With SEC on December 2, 2022)
- Form of Securities Purchase Agreement between Guardion Health Sciences, Inc. and the investors thereto, dated November 29, 2022 (Filed With SEC on December 2, 2022)
- Description of Securities (Filed With SEC on March 31, 2022)
- Warrant Agency Agreement dated as of February 23, 2022, by and between Guardion Health Sciences, Inc., and V Stock Transfer, LLC (Filed With SEC on February 23, 2022)
- Placement Agency Agreement dated as of February 18, 2022, by and between Guardion Health Sciences, Inc., Roth Capital Partners, LLC and Maxim Group LLC (Filed With SEC on February 23, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on February 23, 2022)
- Form of Placement Agent Warrant (Filed With SEC on February 23, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on February 23, 2022)
- Form of Series A/B Warrant (Filed With SEC on February 23, 2022)
- Equity Distribution Agreement dated January 28, 2022 by and among Guardion Health Sciences, Inc., Maxim Group LLC and Roth Capital Partners, LLC (Filed With SEC on January 28, 2022)
- Lease Termination Agreement by and between the Company and Cal-Sorrento, Ltd. dated September 22, 2021 (Filed With SEC on September 23, 2021)
- Employment Agreement by and between the Company and Craig Sheehan dated June 1, 2021 (Filed With SEC on August 16, 2021)
- Employment Agreement by and between the Company and Jeffrey Benjamin dated July 29, 2021 (Filed With SEC on August 2, 2021)
- Equity Purchase Agreement, dated May 18, 2021, by and among the Company, Adare Pharmaceuticals, Inc., and Activ Nutritional, LLC (Filed With SEC on May 21, 2021)
- Description of Securities (Filed With SEC on March 26, 2021)
- Equity Distribution Agreement, dated January 8, 2021, by and between Guardion Health Sciences, Inc. and Maxim Group LLC (Filed With SEC on January 8, 2021)
- Employment Agreement, by and between the Company and Bret Scholtes (Filed With SEC on December 29, 2020)
- Employment Agreement, by and between the Company and Andrew C. Schmidt (Filed With SEC on July 23, 2020)
- Amendment to Consulting Agreement by and between the Company and David Evans (Filed With SEC on June 16, 2020)
- Description of Securities (Filed With SEC on March 30, 2020)
- Underwriting Agreement, dated October 28, 2019 between the Company and the Representatives (Filed With SEC on October 31, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on October 31, 2019)
- Warrant Agreement, including form of Series B Warrant, made as of October 30, 2019, between the Company and VStock (Filed With SEC on October 31, 2019)
- Form of Warrant Agent Agreement (Filed With SEC on October 25, 2019)
- Underwriting Agreement (Filed With SEC on October 25, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on October 25, 2019)
- Form of Series A Warrant (Filed With SEC on October 25, 2019)
- Form of Series B Warrant (Filed With SEC on October 25, 2019)
- Form of Underwriters Warrant (Filed With SEC on October 25, 2019)
- Asset Purchase Agreement, effective September 20, 2019 (Filed With SEC on September 24, 2019)
- Underwriting Agreement, dated August 13, 2019 between the Company and the Representatives (Filed With SEC on August 19, 2019)
- Warrant Agreement, including form of Warrant, made as of August 15, 2019, between the Company and VStock (Filed With SEC on August 19, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on August 19, 2019)
- Form of Warrant (Filed With SEC on August 12, 2019)
- Form of Warrant (Filed With SEC on August 12, 2019)
- Form of Warrant Agent Agreement (Filed With SEC on August 12, 2019)
- Form of Warrant (Filed With SEC on August 7, 2019)
- Form of Underwriters Warrant (Filed With SEC on August 7, 2019)
- Form of Underwriting Agreement (Filed With SEC on August 7, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on August 7, 2019)
- Form of Warrant (Filed With SEC on March 21, 2019)
- Form of Debenture (Filed With SEC on March 21, 2019)
- Form of Purchase Agreement (Filed With SEC on March 21, 2019)
- Form of Underwriting Agreement (Filed With SEC on February 25, 2019)
- Guardion Health Sciences, Inc. 2018 Equity Incentive Plan (Filed With SEC on January 7, 2019)
- Employment Agreement between Guardion Health Sciences, Inc. and Michael Favish (Filed With SEC on December 27, 2018)
- Form of Stock Purchase Agreement (Filed With SEC on November 30, 2018)
- Stock Purchase Agreement dated as of November 3, 2017 (Filed With SEC on November 7, 2017)
- Asset Purchase and Reorganization Agreement dated as of September 29, 2017 (Filed With SEC on October 5, 2017)
- Intellectual Property Assignment Agreement with David W. Evans and VectorVision, Inc. dated as of September 29, 2017 (Filed With SEC on October 5, 2017)
- Consulting Agreement with David W. Evans dated as of September 29, 2017 (Filed With SEC on October 5, 2017)
- Intellectual Property Purchase Agreement with David W. Evans dated as of September 29, 2017 (Filed With SEC on October 5, 2017)
- GUARDION HEALTH SCIENCES, INC. PREFERRED STOCK PURCHASE AGREEMENT SERIES B (Filed With SEC on March 23, 2017)
- GUARDION HEALTH SCIENCES, INC. PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on January 5, 2017)
- GUARDION HEALTH SCIENCES, INC. RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on January 5, 2017)
- AMENDMENT (Filed With SEC on February 11, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on February 11, 2016)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 11, 2016)
- INDUSTRIAL LEASE (Filed With SEC on February 11, 2016)
- PROMISSORYNOTE (Filed With SEC on February 11, 2016)
- WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on February 11, 2016)
- DIRECTOR AND OFFICER INDEMNIFICATIONAGREEMENT (Filed With SEC on February 11, 2016)
- LOAN AGREEMENT (Filed With SEC on February 11, 2016)
- GUARDIONHEALTH SCIENCES, LLC RESTRICTED UNIT PURCHASE AGREEMENT (Filed With SEC on February 11, 2016)
